Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD
NCT ID: NCT04139811
Last Updated: 2019-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2017-03-15
2019-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The incidence of epiretinal membrane formation after vitrectomy for rhegmatogenous detachment has been reported to range from 4.4% to 12.8%.
In this study, the efficacy and safety of internal limiting membrane peeling will be studied in vitrectomy for rhegmatogenous retinal detachment and if it is essential to peel it in those cases or not.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Vitrectomy With ILM Peeling in Myopic Macular Hole With Only Posterior Retinal Detachment
NCT06194760
Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory DME
NCT06271473
Comparison of Vitrectomy Without Internal Limiting Membrane Peeling Versus Inverted ILM Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
NCT04011007
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy
NCT04380064
Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes
NCT01771939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-ILM peeling group
vitrectomy without ILM peeling is done to all cases
Pars Plana Vitrectomy
vitrectomy with and without ILM peeling
ILM peeling group
vitrectomy with ILM peeling is done to all cases
Pars Plana Vitrectomy
vitrectomy with and without ILM peeling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pars Plana Vitrectomy
vitrectomy with and without ILM peeling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with retinal vascular disorders and other macular disorders.
* Combined tractional and rhegmatogenous detachment.
* Previous retinal reattachment surgery or Intravitreal injections.
* Glaucomatous patients.
* Patients with corneal opacity which impairs good visualization.
20 Years
73 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hossam Mohamed Moharram
Assistant professor of ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed F Othman, MD
Role: PRINCIPAL_INVESTIGATOR
sub-investigator
Ahmed Shawkat, MD
Role: PRINCIPAL_INVESTIGATOR
sub-investigator
khalid Murad
Role: PRINCIPAL_INVESTIGATOR
sub-investigator
Mohamed Abdullah
Role: PRINCIPAL_INVESTIGATOR
sub-investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minia UNiversity hospital
Minya, Minya Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Abdullah ME, Moharram HEM, Abdelhalim AS, Mourad KM, Abdelkader MF. Evaluation of primary internal limiting membrane peeling in cases with rhegmatogenous retinal detachment. Int J Retina Vitreous. 2020 May 7;6:8. doi: 10.1186/s40942-020-00213-4. eCollection 2020.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
66-7/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.